JP3146565B2 - Nucleic acid detection method - Google Patents
Nucleic acid detection methodInfo
- Publication number
- JP3146565B2 JP3146565B2 JP28475591A JP28475591A JP3146565B2 JP 3146565 B2 JP3146565 B2 JP 3146565B2 JP 28475591 A JP28475591 A JP 28475591A JP 28475591 A JP28475591 A JP 28475591A JP 3146565 B2 JP3146565 B2 JP 3146565B2
- Authority
- JP
- Japan
- Prior art keywords
- dna
- reaction
- nucleic acid
- labeled
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は特定の塩基配列を持つD
NAあるいはRNAを検出する方法でありウイルスや細
菌による疾患、遺伝病の診断、あるいは種の同定、親子
鑑別などに用いられる方法である。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a DNA having a specific nucleotide sequence.
A method for detecting NA or RNA, which is used for diagnosing a disease or genetic disease caused by a virus or a bacterium, or for identifying a species or discriminating between parent and child.
【0002】[0002]
【従来の技術】ハイブリダイゼーション法は遺伝子の変
異により生じる疾患やウイルスによる病気の診断に有効
である。2. Description of the Related Art Hybridization is effective for diagnosing diseases caused by gene mutation and diseases caused by viruses.
【0003】従来、検出の際には目的DNAやRNAを
菌、ウイルス、白血球などから超音波破砕、などの物理
学的方法、プロテネースKのような酵素やSDSのよう
な界面活性剤を用いて化学的な方法で抽出する。その後
フェノール、クロロホルム処理、エタノール沈澱でDN
A(RNA)を精製した後,NaOHのようなアルカリ
で変性させて1本鎖DNA(RNA)にする。そしてこ
の目的の1本鎖DNA(RNA)をメンブランフィルタ
ー(ニトロセルロース、ナイロン)上に固定する方法が
よく知られたフィルターハイブリダイゼーション法であ
る。[0003] Conventionally, detection has been carried out by using physical methods such as ultrasonic crushing of target DNA or RNA from bacteria, viruses, leukocytes, etc., using enzymes such as proteinase K, and surfactants such as SDS. Extract by chemical method. After that, it was treated with phenol and chloroform, and precipitated with ethanol.
After purifying A (RNA), it is denatured with an alkali such as NaOH to obtain single-stranded DNA (RNA). A well-known filter hybridization method is to fix the single-stranded DNA (RNA) for this purpose on a membrane filter (nitrocellulose, nylon).
【0004】このDNA(RNA)を固定したフィルタ
ーに放射性同位元素、酵素、ビオチン、蛍光物質などで
ラベルしたオリゴヌクレオチドプローブを加えると、オ
リゴヌクレオチドが対象DNA(RNA)と相補的配列
を持つと両者の間に水素結合が生じて2本鎖を形成す
る。相補鎖を持たなっかたり過剰のオリゴヌクレオチド
プローブは洗浄によってフィルターから除去される。そ
の後放射活性、酵素活性、蛍光強度測定によって目的D
NA(RNA)の検出を行う。When an oligonucleotide probe labeled with a radioisotope, an enzyme, biotin, a fluorescent substance, or the like is added to a filter on which the DNA (RNA) is immobilized, if the oligonucleotide has a sequence complementary to the target DNA (RNA), A hydrogen bond occurs between the two to form a double strand. Oligonucleotide probes that have no or no complementary strand are removed from the filter by washing. Thereafter, the objective D is determined by measuring the radioactivity, enzyme activity, and fluorescence intensity
Detection of NA (RNA) is performed.
【0005】また最近よく用いられる微量DNAを増や
す方法にポリメラーゼチェーンリアクション(PCR
(Saiki,R.K.et al,Science 239 487-491 (1988)) があ
る。この方法は、ごく微量の遺伝子(DNA)から目的
とするDNA領域だけを数時間のうちに約100万倍に
増幅させることができる。すなわち、増幅させたい遺伝
子領域を挟んで+鎖、−鎖に対するDNAプライマー
(18〜30ヌクレオチド)を合成しDNAポリメラー
ゼによりDNA断片の合成を繰り返し行うと、1サイク
ルごとにDNAは2倍に増幅されnサイクル後には、2
n 倍に増幅される。この際DNAプライマーとして、目
的遺伝子に特異的な配列を選ぶことで選択性の高いポリ
メラーゼ反応が起こり2つのプライマーにはさまれた2
本鎖DNA断片が生成する。この2本鎖断片の検出法で
は、PCR反応で増幅したDNA(増幅DNA)を先に
述べたフィルターハイブリダイゼーション法に持ち込む
のが一般的な方法である。[0005] In recent years, polymerase chain reaction (PCR)
(Saiki, RK et al, Science 239 487-491 (1988)). This method can amplify only a target DNA region from a very small amount of a gene (DNA) by about one million times within several hours. That is, when DNA primers (18 to 30 nucleotides) for the + and − strands are synthesized across the gene region to be amplified and the synthesis of DNA fragments is repeated by the DNA polymerase, the DNA is amplified twice in each cycle. After n cycles, 2
Amplified n- fold. At this time, by selecting a sequence specific to the target gene as a DNA primer, a highly selective polymerase reaction occurs and the primer
A single-stranded DNA fragment is produced. In this method for detecting a double-stranded fragment, it is a general method to bring DNA amplified by a PCR reaction (amplified DNA) into the above-described filter hybridization method.
【0006】その他の方法としては、あらかじめ各々の
プライマーにビオチンをラベルしてPCR反応を行った
後放射性物質を標識したDNAプロ−ブと液相でハイブ
リダイゼーションを行なった後アビジンを固定したアフ
ィニティマトリックスを用いて検出する方法(Ann-Chris
tine Syvanen et al,Nucl. Acids Res.16 11327-11338
(1988))、オリゴヌクレオチドプロ−ブに複数のビオチ
ンを標識し目的RNAと液相でハイブリダイゼーション
を行った後、アビジンを固定したアフィニティマトリッ
クスと酵素標識抗RNA−DNA抗体を添加して検出す
る方法(Clifford O.Yehle et al, Molecular and Cell
uar Probes 1,177-193(1987)) などがある。As another method, an affinity matrix in which a primer is labeled with biotin in advance, a PCR reaction is performed, a DNA probe labeled with a radioactive substance is hybridized in a liquid phase, and then avidin is immobilized. Detection method using (Ann-Chris
tine Syvanen et al, Nucl. Acids Res. 16 11327-11338
(1988)), oligonucleotide probes were labeled with a plurality of biotins, hybridized with the target RNA in a liquid phase, and then detected by adding an affinity matrix immobilized with avidin and an enzyme-labeled anti-RNA-DNA antibody. Method (Clifford O. Yehle et al, Molecular and Cell
uar Probes 1,177-193 (1987)).
【0007】また増幅DNAを直接、電気泳動法で分析
する方法が知られている。この方法は、アクリルアミド
ゲル担体中で、ラジオアイソトープでラベルした、ある
いはラベルしていないDNA断片を泳動させ、そのゲル
のオートラジオグラフィーをとる、あるいは、薄層シリ
カゲルプレート上におき、UVランプでゲルを照らし写
真をとる。または、アガロースゲル担体中でDNA断片
を泳動し、その後、エチジウムブロマイドでDNAを染
色し、泳動漕からゲルをトランスイルミネーター(紫外
光を発する)上におき、写真をとる方法である(T.Mania
tis et al, Molecular Cloning, Cold Spring Harbour
(1982)) 。[0007] A method of directly analyzing amplified DNA by electrophoresis is also known. In this method, a DNA fragment labeled or not labeled with a radioisotope is electrophoresed in an acrylamide gel carrier, and the gel is subjected to autoradiography, or the gel is placed on a thin-layer silica gel plate, and the gel is placed in a gel with a UV lamp. And take a picture. Alternatively, a DNA fragment is electrophoresed in an agarose gel carrier, the DNA is stained with ethidium bromide, the gel is placed on a transilluminator (which emits ultraviolet light) from the electrophoresis tank, and a photograph is taken (T. Mania
tis et al, Molecular Cloning, Cold Spring Harbor
(1982)).
【0008】またDNAの配列を決定できる方法として
DNAシーケンサーが知られている(Smith,L,M,et al,N
ature 321 674-679(1986))。この方法は蛍光標識したD
NAプライマーを蛍光ラベルしてシーケンスしたいDN
A配列をつなぎアクリルアミドゲルに泳動しアルゴンレ
ーザーを用いてDNA由来の蛍光強度を測定する方法で
ある。A DNA sequencer is known as a method for determining the sequence of DNA (Smith, L, M, et al, N
ature 321 674-679 (1986)). This method uses fluorescently labeled D
DNA to be sequenced by fluorescent labeling of NA primer
In this method, the A-sequences are connected, electrophoresed on an acrylamide gel, and the fluorescence intensity derived from DNA is measured using an argon laser.
【0009】[0009]
【発明が解決しようとする課題】しかしながら、フィル
ターを用いる方法では、フィルターにDNA(RNA)
を固定するための操作、DNA(RNA)を熱や紫外線
によって固定する操作、及び相補鎖を形成しなかったオ
リゴヌクレオチドプロ−ブの洗浄の煩雑な操作がつきま
とう。さらにDNAプロ−ブがフィルター表面に非特異
的に吸着して検出感度の低下やバックグランドの上昇を
招くという不都合もあった。However, in the method using a filter, a DNA (RNA) is used for the filter.
, An operation of fixing DNA (RNA) by heat or ultraviolet rays, and a complicated operation of washing an oligonucleotide probe that did not form a complementary strand. In addition, there is another inconvenience that the DNA probe is non-specifically adsorbed on the surface of the filter, thereby lowering the detection sensitivity and increasing the background.
【0010】またDNAシーケンサー方式を増幅DNA
の検出法にそのまま適応すると検出感度の低下をもたら
すPCR反応に関与しない蛍光色素付きのDNAプライ
マーが泳動ゲルに入ってくるためDNAシーケンサーで
は感度を上げるために働いているレーザー光源を用いて
も十分な感度をかせぐことができない。また本方式では
電気泳動しながらデータを取り込むため数多くのサンプ
ルをこなすことができない。[0010] The DNA sequencer method can be used to amplify DNA.
When applied directly to the detection method, the DNA primer with a fluorescent dye that does not participate in the PCR reaction that causes a decrease in the detection sensitivity will enter the electrophoresis gel. In a DNA sequencer, it is sufficient to use a laser light source that works to increase the sensitivity High sensitivity cannot be earned. In addition, in this method, a large number of samples cannot be processed because data is taken in during electrophoresis.
【0011】またあらかじめ各々のプライマーにビオチ
ンをラベルしてPCR反応を行った後、放射性物質を標
識したDNAプロ−ブと液相でハイブリダイゼーション
を行なった後アビジンを固定したアフィニティマトリッ
クスを用いて検出する方法(Ann-Christine Syvanen et
al,Nucl. Acids Res.16 11327-11338 (1988))では、ハ
イブリダイゼーションを行った後に担体に固定するため
操作が煩雑になる。また放射性物質を用いなければ高感
度が得られない。[0011] In addition, after carrying out PCR reaction by labeling biotin to each primer in advance, hybridization is performed in a liquid phase with a DNA probe labeled with a radioactive substance, and then detection is carried out using an affinity matrix on which avidin is immobilized. (Ann-Christine Syvanen et.
al, Nucl. Acids Res. 16 11327-11338 (1988)), the operation is complicated because it is fixed to a carrier after hybridization. High sensitivity cannot be obtained unless a radioactive substance is used.
【0012】放射性物質を用いる場合は特殊な施設を必
要としかつ高価となる。また彼らはPCR終了後1時間
半以上の時間を要する。また検出の際に遠心操作が必要
である。また彼らは放射性物質のかわりに蛍光色素をも
ちいた方法でも同様な方法を行っているが感度が従来法
(たとえば電気泳動法)に較べて劣るため目的の感度が
得られていない。The use of radioactive materials requires special facilities and is expensive. They also require more than one and a half hours after the end of PCR. In addition, centrifugation is required for detection. They also use the same method using a fluorescent dye instead of a radioactive substance, but the sensitivity is inferior to the conventional method (for example, electrophoresis), and the desired sensitivity has not been obtained.
【0013】そこで、本発明はこれら課題を克服し、放
射性同位元素を用いずに短時間に高感度な多検体処理を
可能とし、手間をかけずに客観的な出力結果を出す核酸
(DNA,RNA)の検出方法を提供することである。Therefore, the present invention overcomes these problems, enables high-sensitivity multi-sample processing in a short time without using a radioisotope, and provides a nucleic acid (DNA, DNA, RNA).
【0014】[0014]
【課題を解決するための手段】本発明は、上記課題を解
決するため、少なくとも1方をラベルした2種のオリゴ
ヌクレオチドを鎖長反応プライマーとして機能させ標的
DNA中の特定のDNAをDNA合成酵素を用いて選択
的に増幅させる工程(第1反応)、次いであらかじめ増
幅断片の1部と相補的な配列を含む標識オリゴヌクレオ
チドと、第1反応で用いたラベルに特異的な物質を固定
したマイクロプレートに第1反応の生成物を添加する工
程(第2反応)、その後第2反応に用いた標識オリゴヌ
クレオチドの標識より生じる信号の測定を行う工程(第
3反応)で目的核酸の有無を検出することを特徴とす
る。Means for Solving the Problems In order to solve the above-mentioned problems, the present invention provides a method in which at least one of two types of oligonucleotides functions as a chain length reaction primer to convert a specific DNA in a target DNA into a DNA synthase. (First reaction), followed by a labeled oligonucleotide containing a sequence complementary to a part of the amplified fragment, and a microtube in which a substance specific to the label used in the first reaction is immobilized. The step of adding the product of the first reaction to the plate (second reaction), and then measuring the signal generated from the labeling of the labeled oligonucleotide used in the second reaction (third reaction) to detect the presence or absence of the target nucleic acid It is characterized by doing.
【0015】ここで、「ラベル」とは、マイクロプレー
トに固定した物質を特異的に認識し、結合するレセプタ
ー物質をいい、例えば、ビオチンを挙げることができる
が、これには限定されない。また、「標識」とは、外部
からオリゴヌクレオチドの挙動をモニタできるような信
号を発する物質をいい、例えば、アルカリフォスファタ
ーゼ、ペルオキシダーゼを挙げることができる。標識に
酵素を使用する場合、酵素基質としては、標識がアルカ
リフォスファターゼの場合には、4−メチルウンベリフ
ェリル燐酸を、ペルオキシダーゼの場合はパラヒドロキ
シフェニルプロピオン酸を用いる。As used herein, the term "label" refers to a receptor substance that specifically recognizes and binds to a substance immobilized on a microplate, and includes, for example, biotin, but is not limited thereto. The term “label” refers to a substance that emits a signal so that the behavior of the oligonucleotide can be monitored from the outside, and examples thereof include alkaline phosphatase and peroxidase. When an enzyme is used for labeling, 4-methylumbelliferyl phosphate is used when the label is alkaline phosphatase, and parahydroxyphenylpropionic acid is used when the label is peroxidase.
【0016】なお、標的核酸がRNAのときは、逆転写
酵素を用いDNAに転写して前記反応を行う。When the target nucleic acid is RNA, the reaction is carried out by transferring the DNA to DNA using reverse transcriptase.
【0017】[0017]
【作用】本発明によれば、目的核酸の有無を電気泳動を
行わずに高感度に、しかも短時間でできるようになる。
また多穴マイクロプレートのような一度に大量のサンプ
ルを処理できる道具を用いると、対象となる核酸の検出
を自動装置化することが可能となる。According to the present invention, the presence or absence of a target nucleic acid can be determined with high sensitivity and in a short time without performing electrophoresis.
In addition, when a tool such as a multi-well microplate that can process a large amount of sample at a time is used, it becomes possible to automate the detection of a target nucleic acid.
【0018】[0018]
(実施例1)第1反応 神奈川現象陽性株であるビブリオ・パラヘモリティカス
WP1 株を液体培養しフェノール、クロロホルムを用いる
常法でトータルDNAを抽出した。そのDNAを紫外可
視吸光光度計を用いて260nm の値からDNA量を定量し
た。この溶液を段階希釈し0.4fg,4fg,40fg,400fg,4000f
g/3ul TE溶液にしてPCRに用いた。PCR反応条件
は,10xバッファー10μl 、dNTP4.8 μl (各1.
25mM)、ビブリオ・パラヘモリティカスtdh 遺伝子特異
的な配列をもつプライマー(a)及び(b)各0.75μl
(25nmol/ml)、ノニデットP-40、ツイーン20各0.5 %3u
l、耐熱性DNAポリメラーゼ 0.15μl( 5unit/ul)を
加えて反応液10μl を調製した。この反応液の入った容
器に、ミネラルオイル(SIGMA 社)を50μl 加えて反応
液を調製した。各バッファーの組成を次に示す。10x
バッファー: 500mM KCl 100mM Tris HC1 15mM MgC
l2 、0.1 %ゼラチン)、dNTP溶液:dATP d
CTP dGTP dTTPの混合物をさす。反応条件
は、以下に示す通りである。(Example 1) Vibrio parahemolyticus which is the first reaction Kanagawa phenomenon positive strain
The WP1 strain was cultured in liquid and total DNA was extracted by a conventional method using phenol and chloroform. The amount of the DNA was quantified from the value at 260 nm using an ultraviolet-visible absorption spectrophotometer. This solution is serially diluted and 0.4fg, 4fg, 40fg, 400fg, 4000f
A g / 3ul TE solution was used for PCR. The PCR reaction conditions were 10 μl of 10 × buffer and 4.8 μl of dNTP (1.
0.75 μl each of primers (a) and (b) having a sequence specific to the Vibrio parahaemolyticus tdh gene
(25 nmol / ml), Nonidet P-40, Tween 20 0.5% each 3u
l, 0.15 µl (5 units / ul) of heat-resistant DNA polymerase was added to prepare 10 µl of a reaction solution. 50 μl of mineral oil (SIGMA) was added to the container containing the reaction solution to prepare a reaction solution. The composition of each buffer is shown below. 10x
Buffer: 500 mM KCl 100 mM Tris HC1 15 mM MgC
l 2, 0.1% gelatin), dNTPs solution: dATP d
CTP dGTP Refers to a mixture of dTTPs. The reaction conditions are as shown below.
【0019】熱変性 94℃ 1分 アニーリング 55℃ 1分 重合反応 72℃ 1分 とし35サイクルおこなった。Thermal denaturation: 94 ° C., 1 minute Annealing: 55 ° C., 1 minute Polymerization reaction: 72 ° C., 1 minute, 35 cycles were performed.
【0020】各プライマーの配列は第64回日本細菌学
会( 多田他 J.J.Bacteriol 199146 281) に報告した配
列である。配列はプライマー(a)5'dGGTACTAAATGGCTGACA
TC3' (b)5'dCCACTACCACTCTCATATGC3'でありビブリオ・
パラヘモリティカスtdh 遺伝子を特異的に検出できるプ
ライマーでありM.Nishibuchi et al. (1990) Mol.Micro
biology 4 87-99 に記載されているtdh2遺伝子の配列中
の配列を用いている。 プライマー(a)(b)ともミリジェ
ン社製DNA合成装置で作製した。(a) は通常の合成の
最終ステップでモノメトキシトリチルアミンリンカーを
反応させて5' 末端にヘキサノールアミン(アミノ基)
を結合させた。脱保護の操作の後C18逆相カラムを備え
た高速液体クロマトグラフィーで精製した。その後(a)
(1OD,5nmol )150 ulを1XPBS(PH7.4) に溶解し15m
M N- ヒドロキシスクシンイミドビオチン(DMF溶液)150
ul と反応させた。室温で1晩反応させた後ゲル濾過カ
ラム(G-25、ファルマシア)で精製しフラクションを減
圧下振とう濃縮し逆相高速液体クロマトグラフィーで精
製してPCRに用いた。プライマー(b) は脱保護後、逆
相高速液体クロマトグラフィーで精製した。PCR終了
後各々2ul ずつを以降の反応に用いた。The sequence of each primer is the sequence reported to the 64th Annual Meeting of the Bacteriological Society of Japan (Tada et al., JJBacteriol 199146 281). Sequence is primer (a) 5'dGGTACTAAATGGCTGACA
TC3 '(b) 5' dCCACTACCACTCTCATATGC3 'and Vibrio
M. Nishibuchi et al. (1990) Mol. Micro is a primer that can specifically detect the parahemolyticus tdh gene.
The sequence in the tdh2 gene described in biology 4 87-99 is used. Both primers (a) and (b) were prepared using a DNA synthesizer manufactured by Milligen. (a) is a reaction of monomethoxytritylamine linker at the final step of the usual synthesis to give a hexanolamine (amino group) at the 5 'end.
Was combined. After the deprotection operation, purification was performed by high performance liquid chromatography equipped with a C18 reverse phase column. Then (a)
Dissolve 150 ul (1 OD, 5 nmol) in 1X PBS (PH7.4)
M N-hydroxysuccinimide biotin (DMF solution) 150
Reacted with ul. After reacting overnight at room temperature, the mixture was purified by a gel filtration column (G-25, Pharmacia), the fraction was shaken under reduced pressure, purified by reversed-phase high performance liquid chromatography, and used for PCR. After deprotection, the primer (b) was purified by reversed-phase high-performance liquid chromatography. After completion of PCR, 2 ul of each was used for the subsequent reactions.
【0021】第2反応 PCR終了後のサンプルを2ul ずつとり1xTE50ulに
溶解し95℃5分加熱後ただちに氷水中に急冷し、1本鎖
DNAに変性した。 Second reaction The sample after completion of PCR was taken in 2 ul portions, dissolved in 50 ul of 1 × TE, heated at 95 ° C. for 5 minutes, immediately quenched in ice water, and denatured into single-stranded DNA.
【0022】その後あらかじめストレプトアビジンを固
定した96穴マイクロプレート(Nunc 社)のウエルに
5’位にアルカリフォスファターゼを標識したオリゴヌ
クレオチド(C) 5'dCCAAATCACTTTTACTTGG3' 100pmol/ml
を20ulを含む、2XSSC,(2.5 XSSC、1%ツイーン20
溶液を30ul、1XTEを50ul、蒸留水50ulを添加してお
いた状態にしておいた96穴マイクロプレートに変性し
たサンプル45ulを添加し室温で15分間放置した。Thereafter, an oligonucleotide (C) labeled with alkaline phosphatase at the 5'-position was added to the well of a 96-well microplate (Nunc) to which streptavidin had been previously fixed. 5 'dCCAAATCACTTTTACTTGG3' 100 pmol / ml
2XSSC, (2.5 XSSC, 1% Tween 20
45 μl of the denatured sample was added to a 96-well microplate to which 30 μl of the solution had been added, 50 μl of 1 × TE, and 50 μl of distilled water, and allowed to stand at room temperature for 15 minutes.
【0023】反応に用いたアルカリフォスファターゼを
標識したオリゴヌクレオチドの作製方法はMurakami,A.e
t al,Nucl.Acid Res.1989.17.5587-5595) 及び多田他、
日本化学会第58春季年会(1989)3IIG31に報告した方法
でおこなった。The method of preparing the oligonucleotide labeled with alkaline phosphatase used in the reaction is described in Murakami, Ae
t al, Nucl. Acid Res. 1989.17.5587-5595) and Tada et al.
The method was reported to the 58th Annual Meeting of the Chemical Society of Japan (1989), 3IIG31.
【0024】またストレプトアビジン固定化96穴マイ
クロプレートの作製は次のように行った。すなわち牛血
清アルブミン(BSA、フラクショV、Sigma 社) 700n
molを1XPBS,500ul に溶解し4.6mg のビオチンアミドカ
プロンサン(Sigma 社、ジメチルアミド溶液)を加え室
温で2-3 時間反応させた。A 96-well microplate immobilized with streptavidin was prepared as follows. That is, bovine serum albumin (BSA, Fraction V, Sigma) 700n
The mol was dissolved in 500 ul of 1XPBS, and 4.6 mg of biotinamide capronsan (Sigma, dimethylamide solution) was added thereto, followed by reaction at room temperature for 2-3 hours.
【0025】反応溶液をG-25ゲルろかカラム(PD-10、フ
ァルマシア)で精製した。その溶液を1XPBS に280nm の
吸光度が0.5OD/mlになるように溶解し96穴マイクロプ
レートに200ul ずつ添加した。4℃で1晩放置したのち
溶液を捨て去り1%BSA、200 ulを各ウエルに添加し
ブロッキングを4℃で1晩行った。溶液を捨て去り、0.
1%ツイーン20を含む1XPBS で2回ウエルを洗浄した後20
ug/ml のストレプトアビジン(BRL 社)を各ウエルに添
加し室温で2−3時間放置させた。次に0.5%ツイーン20
を含む1XPBS で2回ウエルを洗浄して調整したものを用
いた。The reaction solution was purified using a G-25 gel filtration column (PD-10, Pharmacia). The solution was dissolved in 1XPBS so that the absorbance at 280 nm became 0.5 OD / ml, and 200 μl of the solution was added to a 96-well microplate. After leaving at 4 ° C. overnight, the solution was discarded and 200 μl of 1% BSA was added to each well to perform blocking at 4 ° C. overnight. Discard the solution and remove 0.
After washing the wells twice with 1XPBS containing 1% Tween 20, 20
ug / ml streptavidin (BRL) was added to each well and left at room temperature for 2-3 hours. Then 0.5% Tween 20
The wells were adjusted by washing the wells twice with 1XPBS containing.
【0026】室温で15分放置の後、ウエル中の溶液を
捨て去りその後プレートを0.5 %ツィーン20を含む1X
PBS200ul で室温で1分間2回、予め50℃に暖めた
0.5%ツィーン20を含む1XPBS 200ulで1分間1
回、再び室温で1分間1回洗浄した後さらに1XPBS
200ul 、次いで1mM 塩化マグネシウムを含む0.2M トリ
ス塩酸緩衝液(PH9.5)200ulでウエル中の溶液を置換し
た。After standing at room temperature for 15 minutes, the solution in the well was discarded, and the plate was then placed in 1X containing 0.5% Tween 20.
Pre-warmed to 50 ° C twice with 200ul of PBS for 1 minute at room temperature
1 minute in 200ul of 1X PBS containing 0.5% Tween 20 for 1 minute
And once again for 1 minute at room temperature, then 1X PBS
The solution in the wells was replaced with 200 ul and then 200 ul of 0.2 M Tris-HCl buffer (PH9.5) containing 1 mM magnesium chloride.
【0027】第3反応 各ウエルに0.01mM 4−メチルウンベリフェリル燐酸
(Sigma社) 、及び1mM塩化マグネシウムを含む0.2M ト
リス塩酸緩衝液(PH9.5) を200ul 添加し37℃で15分
酵素反応を行った。反応液 150ulをとり400ul の50mM
EDTAを添加し酵素反応を停止させた。その溶液を島津蛍
光分光光度計(RF5000)で励起波長360nm、蛍光波長450nm
で測定した。結果を添付のグラフに示した。本法の結
果を図1に記載した。 Third reaction 200 μl of 0.2 M Tris-HCl buffer (PH9.5) containing 0.01 mM 4-methylumbelliferyl phosphate (Sigma) and 1 mM magnesium chloride was added to each well, and the enzyme was added at 37 ° C. for 15 minutes. The reaction was performed. Take 150ul of reaction solution and 400ul of 50mM
EDTA was added to stop the enzyme reaction. The solution was excited with a Shimadzu spectrophotometer (RF5000) at an excitation wavelength of 360 nm and a fluorescence wavelength of 450 nm.
Was measured. The results are shown in the attached graph. The results of this method are shown in FIG.
【0028】その結果、10コピー以下のビブリオ・パ
ラヘモリティカスWP1 株のDNAをPCR終了後約45
分という短時間で検出できた(S/N=2) 。この結果は,従
来法の電気泳動法に比べ約1−2桁高感度であった。As a result, 10 copies or less of the DNA of Vibrio parahaemolyticus WP1 strain was reduced to about 45
It could be detected in a short time (S / N = 2). This result was about 1-2 orders of magnitude higher sensitivity than the conventional electrophoresis method.
【0029】また本法ではハイブリダイゼーションと9
6穴マイクロプレートへの標的核酸の固定が同時におこ
るがそのことに伴う悪影響は認められなかった。In this method, hybridization and 9
Immobilization of the target nucleic acid on the 6-well microplate occurred at the same time, but no adverse effect was observed.
【0030】(実施例2)この方法の特異性をしらべる
ために臨床分離株23株(ビブリオ・パラヘモリティカ
スWP1 株を含む)を用いて実施例(1)に記載した方法
で行った。Example 2 In order to examine the specificity of this method, 23 clinical isolates (including Vibrio parahaemolyticus WP1 strain) were used in the same manner as described in Example (1).
【0031】各菌株がtdh遺伝子を有しているかどう
かはDNAコロニーハイブリダイゼーションで白井ら
(1989、日本細菌学会誌 44:196)により調べられてい
る。またtdh遺伝子と約83%、68%と高いDNA
ホモロジーを持つ耐熱性溶血毒類似溶血毒遺伝子(tr
h1遺伝子、及びtrh2遺伝子)の有無も同時に記載
した。Whether or not each strain has the tdh gene has been examined by DNA colony hybridization according to Shirai et al. (1989, Journal of the Bacteriological Society of Japan 44: 196). In addition, tdh gene and high DNA of about 83% and 68%
A thermostable hemotoxin-like hemolytic toxin gene with homology ( tr
h 1 gene, and the presence or absence of trh 2 gene) is also described at the same time.
【0032】trh遺伝子の有無は岸下ら(1990、日本
細菌学会誌45:350)によりDNAコロニーハイブリダイ
ゼーションで調べられた。The presence or absence of the trh gene was examined by DNA colony hybridization according to Kishishita et al. (1990, Journal of the Bacteriological Society of Japan 45: 350).
【0033】その結果を図2にプロットした。tdh陽
性株ではすべて蛍光光度(シグナル)が140 以上であっ
た。1方tdh陰性株(trh陰性でtrh1あるいは
trh2陽性株を含む)ではいずれの場合でも蛍光強度
は11以下であった。本法では非常にDNAホモロジー
(相同性)の高いtrh遺伝子と交差反応することなく
tdh遺伝子特異的な検出ができた。The results are plotted in FIG. All the tdh- positive strains had a fluorescence intensity (signal) of 140 or more. 1- sided tdh- negative strain ( trh- negative and trh 1 or
In all cases, the fluorescence intensity was 11 or less. This method does not cross-react with the trh gene, which has a very high DNA homology.
The tdh gene-specific detection was possible.
【0034】以上より、本法は実施例(1)及び(2)
に示したように高感度かつ高特異的にビブリオ・パラヘ
モリティカスtdh遺伝子を特異的に検出できることが
わかった。As described above, the present method is applied to Examples (1) and (2).
As shown in Table 2, it was found that the Vibrio parahaemolyticus tdh gene can be specifically detected with high sensitivity and high specificity.
【0035】[0035]
【発明の効果】本発明によれば、目的核酸の有無を電気
泳動を行わずに高感度に、しかも検出を約45分という
短時間でできるようになる。また96穴マイクロプレー
トのような一度に大量のサンプルを処理できる道具を用
いるため、対象となる核酸の検出を自動装置化すること
が可能となる。According to the present invention, the presence or absence of a target nucleic acid can be detected with high sensitivity without electrophoresis and in a short time of about 45 minutes. In addition, since a tool such as a 96-well microplate that can process a large amount of sample at a time is used, it becomes possible to automate the detection of a target nucleic acid.
【図1】ビブリオ・パラヘモリティカスWP1 株のDNA
を本発明により検出した図[Fig. 1] DNA of Vibrio parahaemolyticus WP1 strain
Figure detected by the present invention
【図2】臨床分離株23株のDNAを本発明により検出
した図FIG. 2 is a diagram showing the DNA of 23 clinical isolates detected according to the present invention.
───────────────────────────────────────────────────── フロントページの続き (58)調査した分野(Int.Cl.7,DB名) C12Q 1/68 G01N 33/50 G01N 33/52 BIOSIS(DIALOG) WPI(DIALOG)──────────────────────────────────────────────────の Continued on the front page (58) Field surveyed (Int. Cl. 7 , DB name) C12Q 1/68 G01N 33/50 G01N 33/52 BIOSIS (DIALOG) WPI (DIALOG)
Claims (1)
ヌクレオチドを鎖長反応プライマーとして機能させ標的
DNA中の特定のDNAをDNA合成酵素を用いて選択
的に増幅させる工程(第1反応)、 次いであらかじめ増幅断片の1部と相補的な配列を含む
標識オリゴヌクレオチドと、第1反応で用いたラベルに
特異的な物質を固定したマイクロプレートに第1反応の
生成物を添加する工程(第2反応)、 その後第2反応に用いた標識オリゴヌクレオチドの標識
より生じる信号の測定を行う工程(第3反応)で目的核
酸の有無を検出する核酸の検出方法。1. a step of using two oligonucleotides labeled at least one of them as a chain length reaction primer to selectively amplify a specific DNA in a target DNA using a DNA synthase (first reaction); Next, a step of adding the product of the first reaction to a microplate in which a labeled oligonucleotide containing a sequence complementary to a part of the amplified fragment and a substance specific to the label used in the first reaction is immobilized (second step) A method for detecting the presence or absence of a target nucleic acid in a step (third reaction) of measuring a signal generated by labeling of the labeled oligonucleotide used in the second reaction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP28475591A JP3146565B2 (en) | 1991-10-30 | 1991-10-30 | Nucleic acid detection method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP28475591A JP3146565B2 (en) | 1991-10-30 | 1991-10-30 | Nucleic acid detection method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH05123197A JPH05123197A (en) | 1993-05-21 |
| JP3146565B2 true JP3146565B2 (en) | 2001-03-19 |
Family
ID=17682587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP28475591A Expired - Fee Related JP3146565B2 (en) | 1991-10-30 | 1991-10-30 | Nucleic acid detection method |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3146565B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09252783A (en) * | 1996-03-26 | 1997-09-30 | Nippon Suisan Kaisha Ltd | Nucleotide for detection of Vibrio parahaemolyticus and detection method using the same |
-
1991
- 1991-10-30 JP JP28475591A patent/JP3146565B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH05123197A (en) | 1993-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wolcott | Advances in nucleic acid-based detection methods | |
| JP3415627B2 (en) | Fluorescence detection assays for homogeneous PCR hybridization systems | |
| JP2846018B2 (en) | Amplification and detection of nucleic acid sequences | |
| JP2719225B2 (en) | Chlamydia trachomatis detection method and kit therefor | |
| JP2561053B2 (en) | Method for detecting Neisseria gonorrhoeae, and reagents and kits therefor | |
| US12460267B2 (en) | Compositions and methods for detection of Mycoplasma genitalium | |
| JPH04506599A (en) | Methods for detecting specific nucleic acid sequences and their applications | |
| JP2939485B2 (en) | Amplification / detection system based on replicated RNA | |
| US6867021B2 (en) | Multiplex RT-PCR/PCR for simultaneous detection of bovine coronavirus, bovine rotavirus, Cryptosporidium parvum, and Escherichia coli | |
| JP2011510630A (en) | Use of a nucleic acid probe to detect a nucleotide sequence of interest present in a sample | |
| US20060252064A1 (en) | Polynucleotide primers and probes for rapid detection of group B streptococcus (GBS) | |
| US5356774A (en) | Replicative RNA-based amplification/detection systems | |
| JPH05507206A (en) | PCR primers for detection of Legionella species and method for adjusting optical intensity in hybridization assay | |
| JP4387479B2 (en) | Assay of trachomachlamydia by amplification and detection of trachomachlamydia latent plasmid | |
| JP5722521B2 (en) | Reagent and method for detecting gonococci | |
| CN104321443A (en) | HEV assay | |
| JP2009520476A (en) | Nucleic acid test controls | |
| JP3146565B2 (en) | Nucleic acid detection method | |
| JP3127135B2 (en) | Amplification and detection of Chlamydia trachomatis nucleic acids | |
| JP3020602B2 (en) | Target nucleic acid amplification / detection system | |
| JPH05227998A (en) | Detection of malarial parasite | |
| JP2715851B2 (en) | Nucleic acid detection method | |
| JP3071797B2 (en) | Replicated RNA-based amplification / detection systems | |
| WO1990003445A1 (en) | Target nucleic acid amplification/detection systems | |
| US7049067B2 (en) | Oligonucleotide for detection of HIV-1 and detection method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080112 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090112 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100112 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100112 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110112 Year of fee payment: 10 |
|
| LAPS | Cancellation because of no payment of annual fees |